Riverwater Partners’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,763
Closed -$31.2K 204
2023
Q3
$31.2K Buy
1,763
+835
+90% +$30.4K 0.03% 186
2023
Q2
$51K Hold
928
0.05% 187
2023
Q1
$63.2K Hold
928
0.06% 187
2022
Q4
$56.3K Buy
928
+358
+63% +$33.3K 0.05% 199
2022
Q3
$57K Hold
570
0.06% 187
2022
Q2
$50K Buy
+570
New +$69.7K 0.05% 190

Other funds holding RBOT

Riverwater Partners's RBOT Position: Q4 2023 in Review

Riverwater Partners sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 1,763 shares — an estimated $31.2K sold.

Riverwater Partners first reported a position in RBOT in Q2 2022 and held it in 6 quarters. The position peaked at $63.2K in Q1 2023. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

  • Riverwater Partners reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
  • Riverwater Partners sold 1,763 Vicarious Surgical shares in Q4 2023, an estimated $31.2K.
  • Riverwater Partners first reported a position in Vicarious Surgical in Q2 2022 and held it in 6 quarters.
  • Riverwater Partners's Vicarious Surgical position peaked at $63.2K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on Riverwater Partners's 13F filing for Q4 2023, filed 5 Jan 2024.